Tech Capital
EPIC: KMK
Market: AIM
52-week High/Low: 37.00p / 18.68p
Sector: Technology Hardware & Equipment
Market Cap: 85.53M
Phone: +44 (0)1740 626060
Address: NETPark, Thomas Wright Way, Sedgefield TS21 3TD.
Website: www.kromek.com

Kromek Group plc is a leading developer of radiation detection solutions based on high performance sensor materials, primarily cadmium zinc telluride (CZT), for applications within the medical, nuclear and security screening markets. Our solutions provide high resolution information on material composition and structure to enable the identification of cancerous tissues and hazardous materials (including explosives), and the analysis of radioactive materials.

With our vertically integrated technology offering and IP portfolio of over 247 patents, Kromek provides an end-to-end solution from the growth of CZT crystals to the design, development and manufacturing of finished products, including software, electronics and ASICs.

Kromek Group PLC

www.kromek.com

Interactive graph

col 3
col 4
col 5
col 6

Big picture - Why invest in Kromek Group PLC

Kromek Group PLC Snapshot

Our Vision
To be the world-leading provider of multispectral radiation detection products and technologies to enable customers and users to take better decisions based on better information.

Increased product integration
Kromek aims to satisfy increasing customer demand for more integrated and complete solutions. Following the acquisition of eV Products, the Board plans to fully integrate its products into the Group's existing offering and develop enhanced solutions.

Further commercialisation of the core technology
The Group plans to further commercialise its core technology through new product development for existing core markets, expansion into new geographical markets with existing products, including the opening of a sales office in Germany, and through licensing its technology in new market sectors.

In particular, the Directors believe that new modalities of nuclear detection, including further forms of cancer screening, as well as a continuing trend for networked sensors will create significant additional opportunities.

Enhanced OEM relationships
The Group will continue to supply its products and subcomponents to OEMs, and will aim to convert its current development contracts into long-term supply agreements. Additionally, the Group will target the development of new key relationships with further OEM partners in its target markets.

Nuclear

Kromek has a portfolio of products for specific detection, identification and quantification of radioactive materials, which are differentiated by their sensitivity, high resolution and small form factor allowing unprecedented flexibility in deployment. Applications include civil radiation detection, industrial process control, environmental monitoring and personal detection use for the public.

For more information, please click here

Medical

Kromek offers detectors and subcomponents for OEM customers in the medical imaging market including CT, SPECT, PET and Bone Mineral Densitometry. Colour imaging enables earlier, more reliable detection of cancer, cardiac conditions and osteoporosis with lower doses of radiation - resulting in better patient outcomes.

For more information, please click here

Security

OEM Solutions

Applications

ASICS

Standard ASICs for x-ray and gamma ray applications

Modern high performance detection systems depend on state-of-the-art ASIC based readout electronics. Whether it is high-energy resolution, high-spatial resolution or high count rate, NOVA ASICs offer a combination of unsurpassed speed and functionality.

For more information, please click here

Technology

Kromek has a diverse technology base and is building expertise based on its core competence of materials technology and advanced x-ray imaging architecture. The company's ability to produce single crystals in the Cadmium Telluride (CdTe) family of materials, on a commercial basis, has enabled it to exploit their energy selectivity in a range of innovative products having both imaging and non imaging applications.

For more information, please click here

SirPeterWilliams3sml

 

 

 

 

Sir Peter Williams, CBE, FREng, FRS, Chairman, and chairman of the Audit Committee

He completed his MA degree and PhD at Cambridge, followed by a Lectureship at Imperial College. He then moved into industry, working at VG Instruments where he became Deputy Chief Executive and at Oxford Instruments, the first spin out from Oxford University, where he held the positions of Chief Executive Officer and Chairman. He also held the roles of Chairman of Isis Innovation Ltd, the technology transfer arm of Oxford University, Chairman of the National Physical Laboratory, Master of St. Catherine’s College Oxford and Vice President and Treasurer of the Royal Society. Other PLC experience includes serving as senior independent director of GKN plc and as a non-executive director of WS Atkins plc. He received a CBE in 1992 and was knighted in the Queen's Birthday Honours list of 1998. He is currently Chairman of the Daiwa Anglo Japanese Foundation in addition to his Kromek responsibilities.  

ms Arnab Basu

                               

 

 

 

Dr Arnab Basu MBE, CEO, has a PhD in physics from Durham University, specialising in semiconducting sensor materials

Arnab held senior management positions in his family business, which manufactured materials for the electronics industry serving over 250 major telecommunications and consumer electronics manufacturers, including Siemens, GEC. He worked in commercial product development for Elmwood Sensors Ltd, (Honeywell Group, UK). A prominent figure within the business community, he was awarded Ernst and Young 'Entrepreneur of the Year' (2009) and received an MBE for services to regional development and international trade (2014).     

ms derek bulmer

 

 

 

 

Mr Derek Bulmer, Executive Director, Chief Financial Officer and in-house Counsel

A qualified Chartered Accountant and Barrister, Derek has worked with KPMG and undertaken a number of senior management roles with blue chip plc's including Bass plc, AWG plc and Ibstock plc. Additionally, and more recently, a number of roles as Finance Director of privately owned groups in both the IT and oil and gas industries have provided a wealth of experience in executing and managing business acquisitions plus significant aspects of the commercial and legal disciplines of corporate management.           

ms Lawrence kinet2

  

 

 

 

Mr Lawrence Kinet, Director and member of the Remuneration Committee

Lawrence has 40 years’ experience in the medical device and bio-pharmaceutical industry in leadership positions, most recently as Group Chief Executive of LMA International NV and, President of Smiths Medical, London. Lawrence has raised more than $100m in funding for early stage companies, taking one through an IPO, and made over $1bn worth of acquisitions. His career began at Baxter International, running a number of overseas operations eventually becoming President of Baxter's International Division. He holds a BSc from the University of Birmingham (UK) and an MBA from the University of Chicago.

                            

ms graeme speirs

 

 

 

 

Dr. Graeme Speirs, Director and member of the Audit Committee

Graeme is an experienced entrepreneur and owner of the Polymer Holdings Group and Polymer N2, an investment company focused on UK start ups in the technology, life sciences and energy sectors. Graeme graduated with first class honours in chemistry and a PhD in molecular physics from Aberdeen University, and holds a masters degree in Technology and Economics from Birmingham University. Involved in the oil and gas industry, Graeme is an expert in the design and manufacture of polymer composite products.         

ms Jerel Whittingham2

 

 

 

 

Mr Jerel Whittingham, Director and Chairman of the Remuneration Committee

Jerel has extensive experience in investor, operational and strategy roles with technology rich companies including Incuvest LLC, Generics Group plc, Durlacher plc, Amphion Innovations plc, INMARSAT and a number of start-ups. He was appointed to the Board of Kromek Group plc in September 2013 and also served on the Board of DSC Ltd, a predecessor company of the group. Currently he combines NED and operational roles in technology growth companies. He also served as CEO and later Executive chairman of Myconostica Ltd, a medical technology company spun out from a leading UK university.

 

For information on the management team, please click here

Significant Shareholders

 

In addition to those disclosed in the Directors Interest section, the Company is aware of the following persons who, at 15 February 2017 have interests in voting rights over 3 percent or more of the issued share capital of the Company:
 

Major Shareholders Shares   %
Miton Group Plc 49,201,886 18.99
Polymer Holdings* 20,273,475 7.82
Herald Investment Management 13,847,059 5.35
Schroders plc 12,941,115 4.99
Killik & Co LLP 10,700,249 4.13
Prof Max Robinson 9,560,000 3.69
NFU Mutual 8,228,569 3.18

 

* Graeme Speirs, a non-executive director of the company, is interested in Polymer Holdings Limited's shareholding in the company as set out above. In addition to his interest in the ordinary shares of the company held by Polymer Holdings Limited set out above, Mr Speirs holds an additional 3,494,940 ordinary shares in the company directly.

Neither the Directors nor any substantial Shareholders have different voting rights to other holders of the share capital of the Company.

This section was last updated on: 15 February 2017

Investor Contacts

 

Director
Dr Arnab Basu
Chief Executive Officer
Reporting Accountants and Auditors
Deloitte LLP
One Trinity Gardens
Broad Chare
Newcastle upon Tyne
NE1 2HF

Company Secretary/ 
In-House Counsel
Derek Bulmer

Lawyers to the Company
Eversheds LLP
Bridgewater Place
Water Lane
Leeds
LS11 5DR

Registered Office
NETPark
Thomas Wright Way
Sedgefield
TS21 3FD
Registrars
Capita Asset Services
The Registry
34 Beckenham Road
Beckenham
Kent
BR3 4TU

Financial Adviser, 
Nominated Adviser and Broker
Cenkos Securities plc
6.7.8 Token House Yard
London
EC2R 7AS

Financial PR Advisers
Luther Pendragon Ltd
Second Floor
48 Gracechurch Street
London
EC3V 0EJ

 

Kromek Group PLC Timeline

View All

Market Reports Including KMK

VIEW ALL

Executive video interviews

VIEW ALL VIDEOS

© tech Capital 2017

Tech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed tech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Tech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Technology market.